Eiger BioPharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Palo Alto, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Eiger BioPharmaceuticals, Inc. has filed 694 SEC EDGAR filings since 05 Oct 2004

SEC filing history

Showing 426-450 of 687 matching filings.

Per page
25
Current page
18
8-K File 001-36183

FORM 8-K

Filing date
17 Aug 2016
Reporting date
17 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-212114

EFFECT filing

Filing date
04 Aug 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
02 Aug 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 333-212114

CT ORDER filing

Filing date
02 Aug 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-212114

AMENDMENT NO. 2 TO FORM S-3

Filing date
02 Aug 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

FORM 8-K

Filing date
28 Jul 2016
Reporting date
18 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36183

DEFINITIVE PROXY STATEMENT

Filing date
22 Jul 2016
Reporting date
29 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-212114

AMENDMENT NO. 1 TO FORM S-3

Filing date
19 Jul 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
15 Jul 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

FORM 8-K

Filing date
23 Jun 2016
Reporting date
17 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Jun 2016
Reporting date
20 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-212114

FORM S-3

Filing date
17 Jun 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-36183

AMENDMENT NO. 2 TO FORM 8-K

Filing date
17 Jun 2016
Reporting date
22 Mar 2016
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jun 2016
Reporting date
13 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 May 2016
Reporting date
19 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-36183

AMENDMENT NO. 1 TO FORM 8-K

Filing date
13 May 2016
Reporting date
22 Mar 2016
Next action
Verify source filing
S-8 File 333-211009

S-8

Filing date
29 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-262254

D filing

Filing date
29 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

FORM 8-K

Filing date
28 Apr 2016
Reporting date
22 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Apr 2016
Reporting date
28 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .